FDA grants clearance for Toshiba’s Infinix 4DCT with Aquilion PRIME CT configuration

15 March 2015 (Last Updated March 15th, 2015 18:30)

The US Food and Drug Administration (FDA) has granted clearance for Toshiba America Medical Systems' new Infinix 4DCT with the Aquilion PRIME CT system configuration.

The US Food and Drug Administration (FDA) has granted clearance for Toshiba America Medical Systems' new Infinix 4DCT with the Aquilion PRIME CT system configuration.

The new combination of interventional labs and CT technology offers features and tools for clinicians to optimise their time and improve patient experience.

The Infinix 4DCT recently secured FDA clearance with the Infinix Elite cardiovascular X-ray system and Aquilion ONE ViSION Edition CT system configuration.

Infinix 4DCT is an all-in-one interventional lab and CT solution designed to offer real-time CT images during procedures instead of CT-like images.

The company said the system improves workflow with its SURE Guidance technology, which provides automatic transition between modalities.

"Infinix 4DCT is an all-in-one interventional lab and CT solution designed to offer real-time CT images during procedures instead of CT-like images."

In addition, the system is capable of saving significant time by enabling clinicians to perform CT and interventional procedures within the same room and verify treatment success following procedures.

According to the company, the Infinix 4DCT maximises workflow of oncology and cardiac procedures, as it provides interventionalists with CT images for the target anatomy.

Instead of relying on CT images taken at an earlier time, clinicians have the ability to adjust the procedure with real-time CT studies.

Toshiba X-ray Vascular Business Unit director Bill Newsom said: "The Infinix 4DCT allows clinicians to plan, treat and verify in a single clinical setting, which negates the need to transfer patients between departments, resulting in anticipated decreases of both procedure time and risk of infection.

"This also contributes to improved patient safety and satisfaction by minimising the clinicians' time spent away from patients, allowing them to focus on providing quality care."

The company will showcase the Infinix 4DCT with the Aquilion PRIME CT at the American College of Cardiology (ACC) annual meeting in San Diego held from 14-16 March.

In the US, the company markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities.